Recording of M4K Pharma’s Scientific Update Meeting – December 4th, 2018.

By | 2018-12-07T21:20:51+00:00 December 7th, 2018|

Recording of M4K Pharma's Scientific Update Meeting - December 4th, 2018 Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. In this meeting, the team provides a comprehensive summary of the project accomplishments at the one year [...]

Recording of M4K Pharma’s Scientific Update Meeting – November 6th, 2018.

By | 2018-11-12T16:46:22+00:00 November 12th, 2018|

Recording of M4K Pharma's Scientific Update Meeting - November 6th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]

M4K Pharma Open Scientific Update Meeting September 2018- Recording

By | 2018-09-13T22:09:31+00:00 September 13th, 2018|

Recording of M4K Pharma's Scientific Update Meeting - September 11th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]

M4K Pharma Open Scientific Update Meeting August 2018- Recording

By | 2018-08-22T09:58:10+00:00 August 22nd, 2018|

Recording of M4K Pharma's Scientific Update Meeting - August 15th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]

Can an open drug discovery model find a solution for rare brain cancers in children?

By | 2018-08-03T11:45:44+00:00 August 1st, 2018|

Can an open drug discovery model find a solution for rare brain cancers in children? Dr. Aled Edwards OICR-funded drug discovery project’s unique ‘open science’ business model is accelerating the search for a solution to lethal pediatric brain cancers. Diffuse intrinsic pontine glioma (DIPG) is a lethal and inoperable brain cancer with a median survival [...]

M4K Pharma Open Scientific Update Meeting July 2018- Recording

By | 2018-08-03T11:46:50+00:00 July 24th, 2018|

Recording of M4K Pharma's Scientific Update Meeting - July 18th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]

M4K Pharma Open Scientific Update Meeting June 2018- Recording

By | 2018-06-15T17:12:40+00:00 June 15th, 2018|

Recording of M4K Pharma's Scientific Update Meeting - June 6th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]

Reaction Biology Joins the Fight Against DIPG with M4K Pharma [News Release]

By | 2018-05-24T14:37:37+00:00 May 24th, 2018|

  Reaction Biology Joins the Fight Against DIPG with M4K Pharma [News Release] Malvern, PA- May 23, 2018. Reaction Biology Corporation (“RBC”), a leading contract research organization providing early stage drug discovery services, announced that it has partnered with M4K Pharma (“M4K”), an open science drug discovery and development company, in the fight against diffuse [...]

M4K Pharma takes part in the Lemon Face Challenge to spread DIPG awareness

By | 2018-05-09T15:52:57+00:00 April 23rd, 2018|

M4K Pharma's Lemon Face Challenge for DIPG Watch the M4K team in Toronto complete the #LemonFaceChallenge to spread DIPG awareness, along with the Structural Genomics Consortium (SGC) and the Ontario Institute for Cancer Research (OICR). Charles River Laboratories met our challenge to them with their own lemon faces in this video here: https://twitter.com/hamblin_nicole/status/989234916872327170 [...]